EU regulators to fine drug makers including Ranbaxy

European regulators will clamp down on "pay-for-delay" deals in the pharmaceutical sector this month, fining Denmark's Lundbeck, India's Ranbaxy and seven other generic drug manufacturers for......

Time for Indian pharma cos to change strategies

It's time for Indian generic companies to rethink their strategies, says Bhupesh Bhandari. In July, the European Commission imposed fines of euro 427.7 million on Servier of France and five......

European Commission fines 9 pharma firms, including Ranbaxy

 The European Commission on Wednesday imposed a fine of Euro146 million on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper generic versions of......

Sun Pharma, Forest settle US suit on Lexapro

Sun Pharmaceutical Industries and its subsidiary, Caraco Pharmaceutical Laboratories, have reached a settlement agreement with drugmaker Forest Laboratories and licensing partner H Lundbeck AS,......